HUP0400923A3 - Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide, process for its preparation, its use and pharmaceutical compositions containing it - Google Patents
Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide, process for its preparation, its use and pharmaceutical compositions containing itInfo
- Publication number
- HUP0400923A3 HUP0400923A3 HU0400923A HUP0400923A HUP0400923A3 HU P0400923 A3 HUP0400923 A3 HU P0400923A3 HU 0400923 A HU0400923 A HU 0400923A HU P0400923 A HUP0400923 A HU P0400923A HU P0400923 A3 HUP0400923 A3 HU P0400923A3
- Authority
- HU
- Hungary
- Prior art keywords
- phenylisoxazol
- benzenesulfonamide
- methyl
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- LNPDTQAFDNKSHK-UHFFFAOYSA-N valdecoxib Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=C(S(N)(=O)=O)C=C1 LNPDTQAFDNKSHK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/34—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements
- H01L23/40—Mountings or securing means for detachable cooling or heating arrangements ; fixed by friction, plugs or springs
- H01L23/4006—Mountings or securing means for detachable cooling or heating arrangements ; fixed by friction, plugs or springs with bolts or screws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/34—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements
- H01L23/42—Fillings or auxiliary members in containers or encapsulations selected or arranged to facilitate heating or cooling
- H01L23/427—Cooling by change of state, e.g. use of heat pipes
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/0001—Technical content checked by a classifier
- H01L2924/0002—Not covered by any one of groups H01L24/00, H01L24/00 and H01L2224/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Power Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Computer Hardware Design (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
- Liquid Crystal Substances (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2437896P | 1996-08-14 | 1996-08-14 | |
| PCT/US1997/015126 WO1998006708A1 (en) | 1996-08-14 | 1997-08-12 | Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0400923A2 HUP0400923A2 (hu) | 2004-08-30 |
| HUP0400923A3 true HUP0400923A3 (en) | 2007-11-28 |
Family
ID=21820280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0400923A HUP0400923A3 (en) | 1996-08-14 | 1997-08-12 | Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide, process for its preparation, its use and pharmaceutical compositions containing it |
Country Status (39)
| Country | Link |
|---|---|
| US (2) | US6441014B2 (lt) |
| EP (2) | EP1283203A1 (lt) |
| JP (2) | JP3631763B2 (lt) |
| KR (1) | KR100383148B1 (lt) |
| CN (1) | CN1205193C (lt) |
| AP (1) | AP1055A (lt) |
| AR (1) | AR009244A1 (lt) |
| AT (1) | ATE228117T1 (lt) |
| AU (1) | AU722072B2 (lt) |
| BG (1) | BG64259B1 (lt) |
| BR (1) | BR9711151A (lt) |
| CA (1) | CA2264104A1 (lt) |
| CZ (1) | CZ297679B6 (lt) |
| DE (1) | DE69717281T2 (lt) |
| DK (1) | DK0920422T3 (lt) |
| EA (2) | EA003754B1 (lt) |
| EE (1) | EE04237B1 (lt) |
| ES (1) | ES2188971T3 (lt) |
| GE (1) | GEP20022636B (lt) |
| HK (1) | HK1023125A1 (lt) |
| HU (1) | HUP0400923A3 (lt) |
| IL (2) | IL128255A (lt) |
| IS (1) | IS1989B (lt) |
| LT (1) | LT4551B (lt) |
| LV (1) | LV12274B (lt) |
| NO (1) | NO312461B1 (lt) |
| NZ (1) | NZ334132A (lt) |
| OA (1) | OA11298A (lt) |
| PL (1) | PL191313B1 (lt) |
| PT (1) | PT920422E (lt) |
| RO (1) | RO120771B1 (lt) |
| RS (1) | RS49671B (lt) |
| SI (1) | SI9720059B (lt) |
| SK (1) | SK283558B6 (lt) |
| TR (1) | TR199900298T2 (lt) |
| TW (1) | TW527350B (lt) |
| UA (1) | UA52684C2 (lt) |
| WO (1) | WO1998006708A1 (lt) |
| ZA (1) | ZA977314B (lt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9711151A (pt) * | 1996-08-14 | 1999-08-17 | Searle & Co | Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida |
| NZ333399A (en) * | 1997-12-24 | 2000-05-26 | Sankyo Co | Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis |
| GB9810920D0 (en) * | 1998-05-21 | 1998-07-22 | Merck Sharp & Dohme | Therapeutic use |
| WO2000008001A1 (en) * | 1998-08-07 | 2000-02-17 | Chiron Corporation | Substituted isoxazole as estrogen receptor modulators |
| AU1398899A (en) * | 1998-11-12 | 2000-06-05 | Algos Pharmaceutical Corporation | Cox-2 inhibitors in combination with centrally acting analgesics |
| NZ513924A (en) * | 1999-03-01 | 2001-09-28 | Ortho Mcneil Pharm Inc | Composition comprising a tramadol material and a selective cox-2 inhibitor drug |
| AU782759B2 (en) | 1999-08-20 | 2005-08-25 | Ortho-Mcneil Pharmaceutical, Inc. | Composition comprising a tramadol material and an anticonvulsant drug |
| EP1212051A4 (en) * | 1999-08-27 | 2004-03-31 | Merck & Co Inc | METHOD FOR TREATING OR PREVENTING CHEMICAL PROSTATITIS OR CHRONIC POOL PAIN |
| DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
| EP3168218B1 (en) * | 2001-08-15 | 2018-11-14 | Pharmacia & Upjohn Company LLC | A crystal comprising an l-malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide for use as a medicament |
| US20070072921A1 (en) * | 2002-07-26 | 2007-03-29 | Talley John J | Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfonamide |
| AU2003238668A1 (en) | 2003-04-04 | 2004-10-25 | Hetero Drugs Limited | Novel crystalline forms of valdecoxib |
| CA2519189C (en) | 2003-05-07 | 2012-07-17 | Osteologix A/S | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
| US20050182113A1 (en) * | 2003-12-30 | 2005-08-18 | Venkataraman Sundaram | Method for preparing diaryl-substituted isoxazole compounds |
| US20050272787A1 (en) * | 2004-05-19 | 2005-12-08 | Eswaraiah Sajja | Process for preparing crystalline form A of valdecoxib |
| WO2005120499A1 (en) * | 2004-06-10 | 2005-12-22 | Chandiran Thakashinamoorthy | Form a of valdecoxib suitable for pharmaceutical formulations |
| MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| SI1612203T1 (sl) * | 2004-06-28 | 2007-12-31 | Gruenenthal Chemie | Kristalne oblike (-)-(1R,2R)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol hidroklorida |
| KR100591786B1 (ko) | 2004-10-19 | 2006-06-26 | 휴먼팜 주식회사 | 프란루카스트를 함유하는 약학적 조성물 및 이의 제조 방법 |
| AU2006249577A1 (en) | 2005-05-20 | 2006-11-30 | Janssen Pharmaceutica N.V. | Process for preparation of sulfamide derivatives |
| US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
| AR058389A1 (es) | 2005-12-19 | 2008-01-30 | Janssen Pharmaceutica Nv | Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad |
| US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| JP2009537635A (ja) | 2006-05-19 | 2009-10-29 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 癲癇の処置のための共同−療法 |
| CA2729056A1 (en) | 2008-06-23 | 2010-01-21 | Janssen Pharmaceutica Nv | Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
| CN103172583A (zh) * | 2013-03-07 | 2013-06-26 | 深圳市资福药业有限公司 | 一种制备帕瑞昔布的方法 |
| US9375417B2 (en) | 2014-12-04 | 2016-06-28 | Mary's Medicinals LLC | Transdermal cannabinoid formulations |
| US10028904B2 (en) | 2014-12-04 | 2018-07-24 | Wisconsin Alumni Research Foundation | Transdermal cannabinoid formulations |
| CN114441666B (zh) * | 2020-11-05 | 2024-02-27 | 成都百裕制药股份有限公司 | 一种4-(5-甲基-3-苯基-4-异恶唑)苯磺酰氯中杂质的检测方法 |
| IL305573A (en) | 2021-03-15 | 2023-10-01 | Saul Yedgar | Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| WO1996025405A1 (en) * | 1995-02-13 | 1996-08-22 | G.D. Searle & Co. | Substituted isoxazoles for the treatment of inflammation |
| US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| US5643933A (en) | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| BR9711151A (pt) * | 1996-08-14 | 1999-08-17 | Searle & Co | Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida |
| AU2003238668A1 (en) * | 2003-04-04 | 2004-10-25 | Hetero Drugs Limited | Novel crystalline forms of valdecoxib |
| US20050272787A1 (en) * | 2004-05-19 | 2005-12-08 | Eswaraiah Sajja | Process for preparing crystalline form A of valdecoxib |
-
1997
- 1997-08-12 BR BR9711151A patent/BR9711151A/pt not_active Application Discontinuation
- 1997-08-12 SI SI9720059A patent/SI9720059B/sl not_active IP Right Cessation
- 1997-08-12 SK SK136-99A patent/SK283558B6/sk not_active IP Right Cessation
- 1997-08-12 AT AT97938656T patent/ATE228117T1/de not_active IP Right Cessation
- 1997-08-12 GE GEAP19974712A patent/GEP20022636B/en unknown
- 1997-08-12 EA EA200000891A patent/EA003754B1/ru not_active IP Right Cessation
- 1997-08-12 IL IL12825597A patent/IL128255A/en not_active IP Right Cessation
- 1997-08-12 CA CA002264104A patent/CA2264104A1/en not_active Abandoned
- 1997-08-12 EE EEP199900053A patent/EE04237B1/xx not_active IP Right Cessation
- 1997-08-12 ES ES97938656T patent/ES2188971T3/es not_active Expired - Lifetime
- 1997-08-12 HU HU0400923A patent/HUP0400923A3/hu unknown
- 1997-08-12 PL PL331607A patent/PL191313B1/pl not_active IP Right Cessation
- 1997-08-12 KR KR10-1999-7001263A patent/KR100383148B1/ko not_active IP Right Cessation
- 1997-08-12 CZ CZ0033499A patent/CZ297679B6/cs not_active IP Right Cessation
- 1997-08-12 DE DE69717281T patent/DE69717281T2/de not_active Expired - Fee Related
- 1997-08-12 JP JP51012198A patent/JP3631763B2/ja not_active Expired - Fee Related
- 1997-08-12 AP APAP/P/1999/001458A patent/AP1055A/en active
- 1997-08-12 EA EA199900200A patent/EA001472B1/ru not_active IP Right Cessation
- 1997-08-12 RO RO99-00176A patent/RO120771B1/ro unknown
- 1997-08-12 EP EP02025507A patent/EP1283203A1/en not_active Withdrawn
- 1997-08-12 IL IL16122497A patent/IL161224A0/xx unknown
- 1997-08-12 DK DK97938656T patent/DK0920422T3/da active
- 1997-08-12 CN CNB971985367A patent/CN1205193C/zh not_active Expired - Fee Related
- 1997-08-12 PT PT97938656T patent/PT920422E/pt unknown
- 1997-08-12 WO PCT/US1997/015126 patent/WO1998006708A1/en active IP Right Grant
- 1997-08-12 AU AU40936/97A patent/AU722072B2/en not_active Ceased
- 1997-08-12 NZ NZ334132A patent/NZ334132A/en unknown
- 1997-08-12 EP EP97938656A patent/EP0920422B1/en not_active Expired - Lifetime
- 1997-08-12 TR TR1999/00298T patent/TR199900298T2/xx unknown
- 1997-08-14 AR ARP970103706A patent/AR009244A1/es not_active Application Discontinuation
- 1997-08-14 ZA ZA977314A patent/ZA977314B/xx unknown
- 1997-10-14 TW TW086111783A patent/TW527350B/zh not_active IP Right Cessation
- 1997-12-08 UA UA99031377A patent/UA52684C2/uk unknown
-
1999
- 1999-01-29 IS IS4961A patent/IS1989B/is unknown
- 1999-02-05 NO NO19990541A patent/NO312461B1/no unknown
- 1999-02-08 BG BG103155A patent/BG64259B1/bg unknown
- 1999-02-12 RS YUP-74/99A patent/RS49671B/sr unknown
- 1999-02-12 OA OA9900031A patent/OA11298A/en unknown
- 1999-03-05 LV LVP-99-40A patent/LV12274B/en unknown
- 1999-03-10 LT LT99-024A patent/LT4551B/lt active Protection Beyond IP Right Term
-
2000
- 2000-04-19 HK HK00102376A patent/HK1023125A1/xx not_active IP Right Cessation
- 2000-12-19 US US09/741,213 patent/US6441014B2/en not_active Expired - Fee Related
-
2002
- 2002-07-26 US US10/205,732 patent/US7135489B2/en not_active Expired - Fee Related
-
2004
- 2004-10-15 JP JP2004301644A patent/JP2005015497A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0400923A3 (en) | Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide, process for its preparation, its use and pharmaceutical compositions containing it | |
| HUP0001652A3 (en) | Oxadiazole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them | |
| HRP960558B1 (en) | New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them | |
| PL345162A1 (en) | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0203902A3 (en) | Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0203841A3 (en) | 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them | |
| HUP9901243A3 (en) | Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
| PL396568A1 (pl) | Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny | |
| HUP0303398A3 (en) | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof and pharmaceutical compositions containing the same | |
| HUP9901037A3 (en) | Piperazine derivatives,preparation and use thereof, pharmaceutical compositions containing these compounds | |
| HUP9801045A3 (en) | Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation | |
| HUP9701194A3 (en) | 4-hydroxy-piperidine derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
| HUP9603237A3 (en) | Crystalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane, process for the preparation thereof and pharmaceutical compositions containing them | |
| HUP0003198A2 (en) | Thermodynamically stable modification of 1-(4-carbazoly-loxy)-3-[2-(2-(methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it | |
| HUP0203597A3 (en) | Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use | |
| HUP9901326A3 (en) | Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions | |
| HUP0202934A3 (en) | Arylsulfonamido-substituted hydroxamic acid derivatives, process for their preparation, pharmaceutical compositions containing them and use thereof | |
| HUP0003053A3 (en) | Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them | |
| HUP0202233A3 (en) | Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them | |
| HUP0000960A3 (en) | Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same | |
| SI1118610T1 (en) | Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| CZ346595A3 (en) | Substituted derivatives of 4-phenylthiazoles, process of their preparation and pharmaceutical compositions containing thereof | |
| HUP9901349A3 (en) | Oxazolidinone derivatives, their preparation and pharmaceutical compositions containing these compounds | |
| HUP9601680A3 (en) | Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds | |
| HUP9801879A3 (en) | Pyridazinone-derivatives as endothelin-receptor antagonists, use thereof, pharmaceutical compositions containing these compounds and process for the preparation of the compounds and the compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |